Soleus Capital Management, L.P.: 13F holdings
CIK 18026302026Q2
| Positions | 97 |
|---|
| Reported value | $2.9bn |
|---|
| Filed | 2026-08-11 |
|---|
Change since last quarter
| Positions | 97 (+4 vs prior quarter) |
|---|
| Reported value | $2.9bn (+17.5%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| KRYS KRYSTAL BIOTECH INC | 939,254 | $349.1m | 12.0% |
| CELC CELCUITY INC | 1,704,318 | $178.3m | 6.1% |
| TGTX TG THERAPEUTICS INC | 2,927,895 | $160.9m | 5.5% |
| PODD INSULET CORP | 1,049,000 | $159.7m | 5.5% |
| NOVOCURE LTD | 9,913,401 | $150.2m | 5.2% |
| UTHR UNITED THERAPEUTICS CORP DEL | 225,587 | $122.2m | 4.2% |
| INSP INSPIRE MED SYS INC | 1,931,436 | $86.2m | 3.0% |
| RIGL RIGEL PHARMACEUTICALS INC | 1,843,504 | $72.1m | 2.5% |
| ANIP ANI PHARMACEUTICALS INC | 867,760 | $71.8m | 2.5% |
| BBNX BETA BIONICS INC | 4,393,714 | $68.8m | 2.4% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1802630")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples